Description
The emergence of new infectious, chronic and drug resistant diseases have prompted scientists to look towards medicinal plants as agents for treatment and prevention. This book provides an interphase between ethnomedical and ethnobotanical approaches to new drug discovery and advances in biotechnology and molecular science that has made it increasingly feasible to transform traditional medicines into modern drugs. These novel approaches also raise new issues and the volume explores economic, ethical and policy considerations of drug development based on indigenous knowledge or traditional medicine.
This work also features standardization and development of phytomedicines for major therapeutic indications, including emerging infectious diseases affecting developing and developed countries.
The publication provides state-of-the-art information on the most innovative science, the research, the industry, the market, and the future of ethnomedicine and drug discovery.
Chapter
Chapter 1. Drugs from nature: past achievements, future prospects
pp.:
38 – 54
Chapter 2. Natural products for high-throughput screening
pp.:
54 – 60
Chapter 3. Medical ethnobotanical research as a method to identify bioactive plants to treat infectious diseases
pp.:
60 – 70
Chapter 4. Development of HerbMed®: an interactive, evidence-based herbal database
pp.:
70 – 76
Chapter 5. Natural products: a continuing source of inspiration for the medicinal chemist
pp.:
76 – 86
Chapter 6. Integrating African ethnomedicine into primary healthcare: a framework for South-eastern Nigeria
pp.:
86 – 96
Chapter 7. Current initiatives in the protection of indigenous and local community knowledge: problems, concepts and lessons for the future
pp.:
96 – 118
Chapter 8. Bioprospecting: using Africa's genetic resources as a new basis for economic development and regional cooperation
pp.:
118 – 132
Chapter 9. Balancing conservation with utilization: restoring populations of commercially valuable medicinal herbs in forests and agroforests
pp.:
132 – 140
Chapter 10. Ethnomedicine of the Cherokee: historical and current applications
pp.:
140 – 148
Chapter 11. Traditional medicines and the new paradigm of psychotropic drug action
pp.:
148 – 160
Chapter 12. Drug discovery through ethnobotany in Nigeria: some results
pp.:
160 – 170
Chapter 13. Plants, products and people: Southern African perspectives
pp.:
170 – 178
Chapter 14. Development of antimalarial agents and drugs for parasitic infections based on leads from traditional medicine: the Walter Reed experience
pp.:
178 – 188
Chapter 15. Health foods in anti-aging therapy: reducers of physiological decline and degenerative diseases
pp.:
188 – 196
Chapter 16. Indigenous peoples and local communities embodying traditional lifestyles: definitions under Article 8(j) of the Convention on Biological Diversity
pp.:
196 – 206
Chapter 17. Garcinia kola: a new look at an old adaptogenic agent
pp.:
206 – 216
Chapter 18. Linking intellectual property rights with traditional medicine
pp.:
216 – 226
Chapter 19. The use of conservation trust funds for sharing financial benefits in bioprospecting projects
pp.:
226 – 256
Chapter 20. The regulation of botanicals as drugs and dietary supplements in Europe
pp.:
256 – 264
Chapter 21. Regulation of herbal medicines in Nigeria: the role of the National Agency for Food and Drug Administration and Control (NAFDAC)
pp.:
264 – 274
Chapter 22. Considerations in the development of public standards for botanicals their dosage forms
pp.:
274 – 282
Chapter 23. The Belize Ethnobotany Project: safeguarding medicinal plants and traditional knowledge in Belize
pp.:
282 – 298
Chapter 24. Ethnobotanical research into the 21st century
pp.:
298 – 324
Chapter 25. Ethnobotanical approach to pharmaceutical drug discovery: strengths and limitations
pp.:
324 – 336
Contributors
pp.:
336 – 340
Subject Index
pp.:
340 – 346
Corrigendum
pp.:
346 – 348